2. Consider a scenario where two vaccines have been developed and their effectiveness was tested by comparing the mean outcome for a vaccinated group to the mean for a control (placebo) group. Both of...


How would you explain question a in detail?


2. Consider a scenario where two vaccines have been developed and their effectiveness was tested by<br>comparing the mean outcome for a vaccinated group to the mean for a control (placebo) group. Both of<br>the vaccine studies set the significance (a) level for the test at .05, two-tailed, and both found statistically<br>significant differences (i.e., the p-value was very small and Ho was rejected). The results were as follows:<br>Study<br>Effect size (d)<br>t-statistic<br>Vaccine 1<br>0.7<br>4.8<br>Vaccine 2<br>0.2<br>4.8<br>(a) Based on the above information, can we know whether one study involved a larger sample size<br>than the other? If so, which one? Explain.<br>(b) Based on the above information, can we conclude that one vaccine is preferable to (i.e., more<br>effective than) the other? If so, which one? Explain.<br>

Extracted text: 2. Consider a scenario where two vaccines have been developed and their effectiveness was tested by comparing the mean outcome for a vaccinated group to the mean for a control (placebo) group. Both of the vaccine studies set the significance (a) level for the test at .05, two-tailed, and both found statistically significant differences (i.e., the p-value was very small and Ho was rejected). The results were as follows: Study Effect size (d) t-statistic Vaccine 1 0.7 4.8 Vaccine 2 0.2 4.8 (a) Based on the above information, can we know whether one study involved a larger sample size than the other? If so, which one? Explain. (b) Based on the above information, can we conclude that one vaccine is preferable to (i.e., more effective than) the other? If so, which one? Explain.

Jun 11, 2022
SOLUTION.PDF

Get Answer To This Question

Related Questions & Answers

More Questions ยป

Submit New Assignment

Copy and Paste Your Assignment Here